CA-II, ADH1C, CEH, IgGFc-binding protein, and ADH1B were all found to be less-abundant proteins in both regions of the tumor analyzed, suggesting their possible down-expression in CRC cells. The gene discussed is ADH1B; the disease is neoplasm.